Clinically significant increases (> 3 times the upper limit of normal) of serum transaminase levels were observed in 0.8% of patients treated with atorvastatin.
Okubaluleke kakhulu ngokwezempilo (izikhathi ezi-3 eziphakeme kunomkhawulo ophezulu wejwayelekile) ukwanda kwama-serum transaminases kwabonwa ku-0.8% weziguli ezithola i-atorvastatin.